InsidersTradesSigma
Follow the Chordia Therapeutics 株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). The latest transaction was reported on 10 March 2026 (Holding update). Among the most active insiders: Kyoto University Innovation Capital Co.,Ltd.. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Chordia Therapeutics 是一家日本公司，专注于开发创新疗法。它在东京证券交易所运营，股票代码为 XTKS。